{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:50:22Z","timestamp":1768549822813,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","award":["GZ-2016-11637"],"award-info":[{"award-number":["GZ-2016-11637"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pain occurs in the majority of patients with late onset Pompe disease (LOPD) and is associated with a reduced quality of life. The aim of this study was to analyse the pain characteristics and its relation to a small nerve fiber involvement in LOPD patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In 35 patients with LOPD under enzyme replacement therapy without clinical signs of polyneuropathy (19 females; 51\u2009\u00b1\u200915\u00a0years), pain characteristics as well as depressive and anxiety symptoms were assessed using the PainDetect questionnaire (PDQ) and the hospital anxiety and depression scale (HADS), respectively. Distal skin biopsies were analysed for intraepidermal nerve fiber density (IENFD) and compared to age- and gender-matched reference data. Skin biopsies from 20 healthy subjects served as controls to assure validity of the morphometric analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Pain was reported in 69% of the patients with an average intensity of 4.1\u2009\u00b1\u20091.1 on the numeric rating scale (NRS; anchors: 0\u201310). According to PDQ, neuropathic pain was likely in one patient, possible in 29%, and unlikely in 67%. Relevant depression and anxiety symptoms occurred in 31% and 23%, respectively, and correlated with pain intensity. Distal IENFD (3.98\u2009\u00b1\u20091.95 fibers\/mm) was reduced in 57% of the patients. The degree of IENFD reduction did not correlate with the durations of symptoms to ERT or duration of ERT to biopsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Pain is a frequent symptom in treated LOPD on ERT, though a screening questionnaire seldom indicated neuropathic pain. The high frequency of small nerve fiber pathology in a treated LOPD cohort was found regardless of the presence of pain or comorbid risk factors for SFN and needs further exploration in terms of clinical context, exact mechanisms and when developing novel therapeutic options for LOPD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02327-4","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T11:03:15Z","timestamp":1651057395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Small fiber involvement is independent from clinical pain in late-onset Pompe disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Elena K.","family":"Enax-Krumova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Dahlhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"G\u00f6rlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristl G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Montagnese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"llka","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Fangerau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Schlierbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia V.","family":"Wanschitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang N.","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Katrin","family":"G\u00fcttsches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Vielhaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Hasseli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Zunk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun H.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Rosenbohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-2028","authenticated-orcid":false,"given":"Anne","family":"Sch\u00e4nzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"2327_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/bj2720493","volume":"272","author":"LH Hoefsloot","year":"1990","unstructured":"Hoefsloot LH, Hoogeveen-Westerveld M, Reuser AJ, Oostra BA. Characterization of the human lysosomal alpha-glucosidase gene. Biochem J. 1990;272:493\u20137.","journal-title":"Biochem J"},{"key":"2327_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13023-014-0102-z","volume":"9","author":"P De Filippi","year":"2014","unstructured":"De Filippi P, Saeidi K, Ravaglia S, Dardis A, Angelini C, Mongini T, Morandi L, Moggio M, Di Muzio A, Filosto M, et al. Genotype-phenotype correlation in Pompe disease, a step forward. Orphanet J Rare Dis. 2014;9:102.","journal-title":"Orphanet J Rare Dis"},{"key":"2327_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00415-015-7664-0","volume":"262","author":"F Montagnese","year":"2015","unstructured":"Montagnese F, Barca E, Musumeci O, Mondello S, Migliorato A, Ciranni A, Rodolico C, De Filippi P, Danesino C, Toscano A. Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment. J Neurol. 2015;262:968\u201378.","journal-title":"J Neurol"},{"key":"2327_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","volume":"68","author":"MA Kroos","year":"2007","unstructured":"Kroos MA, Pomponio RJ, Hagemans ML, Keulemans JL, Phipps M, DeRiso M, Palmer RE, Ausems MG, Van Beek NA, Van Diggelen OP, et al. Broad spectrum of Pompe disease in patients with the same c.-32\u201313T>G haplotype. Neurology. 2007;68:110\u20135.","journal-title":"Neurology"},{"key":"2327_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ajmg.c.31318","volume":"160c","author":"M Kroos","year":"2012","unstructured":"Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser AJ. The genotype-phenotype correlation in Pompe disease. Am J Med Genet C Semin Med Genet. 2012;160c:59\u201368.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2327_CR6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/humu.22108","volume":"33","author":"M Kroos","year":"2012","unstructured":"Kroos M, Hoogeveen-Westerveld M, Michelakakis H, Pomponio R, Van der Ploeg A, Halley D, Reuser A. Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants. Hum Mutat. 2012;33:1161\u20135.","journal-title":"Hum Mutat"},{"key":"2327_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1750-1172-8-159","volume":"8","author":"S Sampaolo","year":"2013","unstructured":"Sampaolo S, Esposito T, Farina O, Formicola D, Diodato D, Gianfrancesco F, Cipullo F, Cremone G, Cirillo M, Del Viscovo L, et al. Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship. Orphanet J Rare Dis. 2013;8:159.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2327_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/nan.12580","volume":"46","author":"M Kulessa","year":"2020","unstructured":"Kulessa M, Weyer-Menkhoff I, Viergutz L, Kornblum C, Claeys KG, Schneider I, Pl\u00f6ckinger U, Young P, Boentert M, Vielhaber S, et al. An integrative correlation of myopathology, phenotype, and genotype in late onset Pompe disease. Neuropathol Appl Neurobiol. 2020;46(4):359\u201374.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2327_CR9","doi-asserted-by":"crossref","unstructured":"Hahn A, Sch\u00e4nzer A. Long-term outcome and unmet needs in infantile-onset Pompe disease. Ann Transl Med. 2019;283.","DOI":"10.21037\/atm.2019.04.70"},{"key":"2327_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymgme.2016.05.013","volume":"119","author":"A van der Ploeg","year":"2016","unstructured":"van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S, Pestronk A, Barohn RJ, Dimachkie MM, Goker-Alpan O, et al. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: the EMBASSY Study. Mol Genet Metab. 2016;119:115\u201323.","journal-title":"Mol Genet Metab"},{"key":"2327_CR11","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JM Van den Hout","year":"2004","unstructured":"Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics. 2004;113:e448-457.","journal-title":"Pediatrics"},{"issue":"4","key":"2327_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","volume":"264","author":"B Schoser","year":"2017","unstructured":"Schoser B, Stewart A, Kanters S, Hamed A, Jansen J, Chan K, Karamouzian M, Toscano A. Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis. J Neurol. 2017;264(4):621\u201330.","journal-title":"J Neurol"},{"issue":"2","key":"2327_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymgme.2017.10.005","volume":"123","author":"PT McIntosh","year":"2018","unstructured":"McIntosh PT, Hobson-Webb LD, Kazi ZB, Prater SN, Banugaria SG, Austin S, Wang R, Enterline DS, Frush DP, Kishnani PS. Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy. Mol Genet Metab. 2018;123(2):85\u201391.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2327_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/dmcn.13740","volume":"60","author":"BJ Ebbink","year":"2018","unstructured":"Ebbink BJ, Poelman E, Aarsen FK, Plug I, Regal L, Muentjes C, van der Beek N, Lequin MH, van der Ploeg AT, van den Hout JMP. Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain. Dev Med Child Neurol. 2018;60(6):59\u2013586.","journal-title":"Dev Med Child Neurol"},{"key":"2327_CR15","doi-asserted-by":"crossref","unstructured":"Sch\u00e4nzer A, G\u00f6rlach J, Claudi K, Hahn A. Severe distal muscle involvement and mild sensory neuropathy in a boy with infantile onset Pompe disease treated with enzyme replacement therapy for 6 years. Neuromuscul Disord. 2019;477\u2013482.","DOI":"10.1016\/j.nmd.2019.03.004"},{"key":"2327_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.nmd.2019.08.016","volume":"29","author":"SMM Lamartine","year":"2019","unstructured":"Lamartine SMM, Remiche G. Late-onset Pompe disease associated with polyneuropathy. Neuromuscul Disord. 2019;29:968\u201372.","journal-title":"Neuromuscul Disord"},{"key":"2327_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.21037\/atm.2019.07.24","volume":"7","author":"A Toscano","year":"2019","unstructured":"Toscano A, Rodolico C, Musumeci O. Multisystem late onset Pompe disease (LOPD): an update on clinical aspects. Ann Transl Med. 2019;7:284.","journal-title":"Ann Transl Med"},{"key":"2327_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ymgme.2013.05.021","volume":"109","author":"D G\u00fcng\u00f6r","year":"2013","unstructured":"G\u00fcng\u00f6r D, Schober AK, Kruijshaar ME, Plug I, Karabul N, Deschauer M, van Doorn PA, van der Ploeg AT, Schoser B, Hanisch F. Pain in adult patients with Pompe disease: a cross-sectional survey. Mol Genet Metab. 2013;109:371\u20136.","journal-title":"Mol Genet Metab"},{"key":"2327_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41746-019-0143-8","volume":"2","author":"A Hamed","year":"2019","unstructured":"Hamed A, Curran C, Gwaltney C, DasMahapatra P. Mobility assessment using wearable technology in patients with late-onset Pompe disease. NPJ Digit Med. 2019;2:70.","journal-title":"NPJ Digit Med"},{"key":"2327_CR20","doi-asserted-by":"crossref","unstructured":"Schoser B, Bilder DA, Dimmock D, Gupta D, James ES, Prasad S. The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurol. 17","DOI":"10.1186\/s12883-017-0983-2"},{"key":"2327_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/mus.24618","volume":"52","author":"A Gesquiere-Dando","year":"2015","unstructured":"Gesquiere-Dando A, Attarian S, Maues De Paula A, Pouget J, Salort-Campana E. Fibromyalgia-like symptoms associated with irritable bowel syndrome: a challenging diagnosis of late-onset Pompe disease. Muscle Nerve. 2015;52:300\u20134.","journal-title":"Muscle Nerve"},{"key":"2327_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.apmr.2014.11.020","volume":"96","author":"MM Favejee","year":"2015","unstructured":"Favejee MM, van den Berg LE, Kruijshaar ME, Wens SC, Praet SF, Pim Pijnappel WW, van Doorn PA, Bussmann JB, van der Ploeg AT. Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning. Arch Physl Med Rehabil. 2015;96:817\u201322.","journal-title":"Arch Physl Med Rehabil"},{"key":"2327_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ymgmr.2014.02.007","volume":"1","author":"N Karabul","year":"2014","unstructured":"Karabul N, Kruijshaar ME, Schober A, G\u00fcng\u00f6r D, Hanisch F. Pain in adult patients with Pompe disease. Mol Genet Metab Rep. 2014;1:139\u201340.","journal-title":"Mol Genet Metab Rep"},{"key":"2327_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/mus.26766","volume":"61","author":"J G\u00f6rlach","year":"2020","unstructured":"G\u00f6rlach J, Amsel D, K\u00f6lbel H, Grzybowsky M, Rutsch F, Schlierbach H, Vanlander A, Pogatzki-Zahn E, Habig K, Garkisch S, et al. Diagnostic utility of small fiber analysis in skin biopsies from children with chronic pain. Muscle Nerve. 2020;61:173\u201381.","journal-title":"Muscle Nerve"},{"issue":"1","key":"2327_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jns.12298","volume":"24","author":"M Sopacua","year":"2019","unstructured":"Sopacua M, Hoeijmakers JGJ, Merkies ISJ, Lauria G, Waxman SG, Faber CG. Small fibre neuropathy: expanding the clinical pain universe. J Peripher Nerv Syst. 2019;24(1):19\u20133326.","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 1","key":"2327_CR26","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1097\/j.pain.0000000000000411","volume":"157","author":"N \u00dc\u00e7eyler","year":"2016","unstructured":"\u00dc\u00e7eyler N. Small fiber pathology\u2013a culprit for many painful disorders? Pain. 2016;157(Suppl 1):S60-66.","journal-title":"Pain"},{"key":"2327_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.12659\/AJCR.893309","volume":"16","author":"LD Hobson-Webb","year":"2015","unstructured":"Hobson-Webb LD, Austin SL, Jain S, Case LE, Greene K, Kishnani PS. Small-fiber neuropathy in pompe disease: first reported cases and prospective screening of a clinic cohort. Am J Case Rep. 2015;16:196\u2013201.","journal-title":"Am J Case Rep"},{"key":"2327_CR28","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911\u201320.","journal-title":"Curr Med Res Opin"},{"key":"2327_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1055\/s-2001-13279","volume":"51","author":"A Hinz","year":"2001","unstructured":"Hinz A, Schwarz R. Anxiety and depression in the general population: normal values in the Hospital Anxiety and Depression Scale. Psychother Psychosom Med Psychol. 2001;51:193\u2013200.","journal-title":"Psychother Psychosom Med Psychol"},{"key":"2327_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"2327_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/B978-0-7216-9491-7.50037-5","volume-title":"Peripheral neuropathy","author":"WR Kennedy","year":"2005","unstructured":"Kennedy WR, Wendelschaefer-Crabb G, Polydefkis M, McArthur JC. Pathology and quantitation of cutaneous innervation. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsvier Saunders; 2005. p. 869\u201395."},{"key":"2327_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","volume":"15","author":"G Lauria","year":"2010","unstructured":"Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, Smith AG, Hsieh ST, Mellgren SI, Umapathi T, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst. 2010;15:202\u20137.","journal-title":"J Peripher Nerv Syst"},{"key":"2327_CR33","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2337\/dc14-2311","volume":"38","author":"M Tavakoli","year":"2015","unstructured":"Tavakoli M, Ferdousi M, Petropoulos IN, Morris J, Pritchard N, Zhivov A, Ziegler D, Pacaud D, Romanchuk K, Perkins BA, et al. Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set. Diabetes Care. 2015;38:838\u201343.","journal-title":"Diabetes Care"},{"key":"2327_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/ICO.0000000000001949","volume":"38","author":"D Sturm","year":"2019","unstructured":"Sturm D, Vollert J, Greiner T, Rice ASC, Kemp H, Treede RD, Schuh-Hofer S, Nielsen SE, Eitner L, Tegenthoff M, et al. Implementation of a quality index for improvement of quantification of corneal nerves in corneal confocal microcopy images: a multicenter study. Cornea. 2019;38:921\u20136.","journal-title":"Cornea"},{"key":"2327_CR35","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/j.pain.0000000000001287","volume":"159","author":"N \u00dc\u00e7eyler","year":"2018","unstructured":"\u00dc\u00e7eyler N, Vollert J, Broll B, Riediger N, Langjahr M, Saffer N, Schubert AL, Siedler G, Sommer C. Sensory profiles and skin innervation of patients with painful and painless neuropathies. Pain. 2018;159:1867\u201376.","journal-title":"Pain"},{"key":"2327_CR36","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1093\/brain\/awz333","volume":"142","author":"G Devigili","year":"2019","unstructured":"Devigili G, Rinaldo S, Lombardi R, Cazzato D, Marchi M, Salvi E, Eleopra R, Lauria G. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019;142:3728\u201336.","journal-title":"Brain"},{"key":"2327_CR37","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S1474-4422(17)30329-0","volume":"16","author":"AJ Terkelsen","year":"2017","unstructured":"Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol. 2017;16:934\u201344.","journal-title":"Lancet Neurol"},{"key":"2327_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.rmed.2010.09.014","volume":"105","author":"E Hoitsma","year":"2011","unstructured":"Hoitsma E, De Vries J, Drent M. The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis. Respir Med. 2011;105:95\u2013100.","journal-title":"Respir Med"},{"key":"2327_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ymgme.2012.05.007","volume":"106","author":"LD Hobson-Webb","year":"2012","unstructured":"Hobson-Webb LD, Proia AD, Thurberg BL, Banugaria S, Prater SN, Kishnani PS. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab. 2012;106:462\u20139.","journal-title":"Mol Genet Metab"},{"key":"2327_CR40","doi-asserted-by":"crossref","unstructured":"Jiang MS, Yuan Y, Gu ZX, Zhuang SL: Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis. Br J Ophthalmol. 2016;100","DOI":"10.1136\/bjophthalmol-2014-306038"},{"key":"2327_CR41","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/ICO.0000000000000535","volume":"34","author":"F Bucher","year":"2015","unstructured":"Bucher F, Schneider C, Blau T, Cursiefen C, Fink GR, Lehmann HC, Heindl LM. Small-fiber neuropathy is associated with corneal nerve and dendritic cell alterations: an in vivo confocal microscopy study. Cornea. 2015;34:1114\u20139.","journal-title":"Cornea"},{"key":"2327_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139394","volume":"10","author":"M Ferdousi","year":"2015","unstructured":"Ferdousi M, Azmi S, Petropoulos IN, Fadavi H, Ponirakis G, Marshall A, Tavakoli M, Malik I, Mansoor W, Malik RA. Corneal confocal microscopy detects small fibre neuropathy in patients with upper gastrointestinal cancer and nerve regeneration in chemotherapy induced peripheral neuropathy. PLoS ONE. 2015;10: e0139394.","journal-title":"PLoS ONE"},{"key":"2327_CR43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jamaophthalmol.2017.1703","volume":"135","author":"HI Kemp","year":"2017","unstructured":"Kemp HI, Petropoulos IN, Rice ASC, Vollert J, Maier C, Strum D, Schargus M, Peto T, Hau S, Chopra R, et al. Use of corneal confocal microscopy to evaluate small nerve fibers in patients with human immunodeficiency virus. JAMA Ophthalmol. 2017;135:795\u2013800.","journal-title":"JAMA Ophthalmol"},{"key":"2327_CR44","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mus.21383","volume":"40","author":"M Tavakoli","year":"2009","unstructured":"Tavakoli M, Marshall A, Thompson L, Kenny M, Waldek S, Efron N, Malik RA. Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease. Muscle Nerve. 2009;40:976\u201384.","journal-title":"Muscle Nerve"},{"key":"2327_CR45","doi-asserted-by":"crossref","unstructured":"Erkan Turan K, Kocabeyoglu S, Bekircan-Kurt CE, Bezci F, Erdem-Ozdamar S, Irkec M. Ocular surface alterations and in vivo confocal microscopic characteristics of corneas in patients with myasthenia gravis. Eur J Ophthalmol. 2018;541\u2013546.","DOI":"10.1177\/1120672117753688"},{"key":"2327_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/8904_2015_426","volume":"23","author":"LD Pena","year":"2015","unstructured":"Pena LD, Proia AD, Kishnani PS. Postmortem findings and clinical correlates in individuals with infantile-onset pompe disease. JIMD reports. 2015;23:45\u201354.","journal-title":"JIMD reports"},{"key":"2327_CR47","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mus.10381","volume":"27","author":"LP Winkel","year":"2003","unstructured":"Winkel LP, Kamphoven JH, van den Hout HJ, Severijnen LA, van Doorn PA, Reuser AJ, van der Ploeg AT. Morphological changes in muscle tissue of patients with infantile Pompe\u2019s disease receiving enzyme replacement therapy. Muscle Nerve. 2003;27:743\u201351.","journal-title":"Muscle Nerve"},{"key":"2327_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/nan.12332","volume":"43","author":"M Nolano","year":"2017","unstructured":"Nolano M, Provitera V, Manganelli F, Iodice R, Caporaso G, Stancanelli A, Marinou K, Lanzillo B, Santoro L, Mora G. Non-motor involvement in amyotrophic lateral sclerosis: new insight from nerve and vessel analysis in skin biopsy. Neuropathol Appl Neurobiol. 2017;43:119\u201332.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2327_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1172-9-17","volume":"9","author":"I Katona","year":"2014","unstructured":"Katona I, Weis J, Hanisch F. Glycogenosome accumulation in the arrector pili muscle in Pompe disease. Orphanet J Rare Dis. 2014;9:17.","journal-title":"Orphanet J Rare Dis"},{"key":"2327_CR50","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/hmg\/ddu476","volume":"24","author":"DJ Falk","year":"2015","unstructured":"Falk DJ, Todd AG, Lee S, Soustek MS, ElMallah MK, Fuller DD, Notterpek L, Byrne BJ. Peripheral nerve and neuromuscular junction pathology in Pompe disease. Hum Mol Genet. 2015;24:625\u201336.","journal-title":"Hum Mol Genet"},{"key":"2327_CR51","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","volume":"67","author":"RL Sidman","year":"2008","unstructured":"Sidman RL, Taksir T, Fidler J, Zhao M, Dodge JC, Passini MA, Raben N, Thurberg BL, Cheng SH, Shihabuddin LS. Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice. J Neuropathol Exp Neurol. 2008;67:803\u201318.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2327_CR52","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DLH, Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157:1599\u2013606.","journal-title":"Pain"},{"key":"2327_CR53","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/14737175.2020.1794825","volume":"20","author":"G Devigili","year":"2020","unstructured":"Devigili G, Cazzato D, Lauria G. Clinical diagnosis and management of small fiber neuropathy: an update on best practice. Expert Rev Neurother. 2020;20:967\u201380.","journal-title":"Expert Rev Neurother"},{"key":"2327_CR54","doi-asserted-by":"publisher","first-page":"175628642110043","DOI":"10.1177\/17562864211004318","volume":"14","author":"N Egenolf","year":"2021","unstructured":"Egenolf N, Altenschildesche CMz, Kre\u00df L, Eggermann K, Namer B, Gross F, Klitsch A, Malzacher T, Kampik D, Malik RA, et al. Diagnosing small fiber neuropathy in clinical practice: a deep phenotyping study. Ther Adv Neurol Disord. 2021;14:17562864211004318.","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02327-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T12:12:22Z","timestamp":1651061542000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02327-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2327"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02327-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the central Ethics Committee of the University of Giessen (AZ07\/09) as well as the local ethic committees from the participating centres and was conducted according to the current version of the Guidelines for Good Clinical Practice and Helsinki Declaration of the World Medical Association. All included subjects gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest in respect of the manuscript content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}